Related Experiment Video

Updated: Jun 7, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

[The best of congenital heart disease in 2006]

C Rey1

  • 1Service des maladies cardiovasculaires infantiles et congénitales, Hôpital cardiologique, 59037 Lille Cedex. crey@chru-lille.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux
|April 5, 2007
PubMed

Insights

Recent publications highlight advances in interventional cardiology for congenital heart disease. Key areas include percutaneous closure of septal defects and managing arrhythmias in pediatric and adult patients.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Interventional Cardiology

Context:

  • The period of 2005-2006 saw a significant increase in research publications concerning congenital heart disease (CHD) in both pediatric and adult populations.
  • Interventional cardiology continues to be a major focus, with ongoing randomized and non-randomized trials exploring new treatment modalities.
  • Specific areas of interest include the closure of the foramen ovale for cerebrovascular accidents and migraine, percutaneous closure of atrial septal defects, and ventricular septal defects.

Purpose:

  • To review and summarize the key advancements and trends in the management of congenital heart disease published during 2005-2006.
  • To highlight the evolving role of interventional cardiology in treating pediatric and adult CHD.
  • To discuss emerging research on arrhythmias, long-term outcomes, and reproductive health in individuals with CHD.

Summary:

  • Publications from 2005-2006 demonstrate significant progress in interventional cardiology for CHD, including percutaneous closure techniques for various septal defects and conduit obstructions.
  • Research also focused on the management of arrhythmias in CHD patients, utilizing devices like implantable automatic defibrillators and exploring resynchronization therapies.
  • Long-term outcomes, particularly for women with a history of childhood heart surgery, including fertility and pregnancy complications, were a notable area of investigation.

Impact:

  • The findings underscore the expanding capabilities of interventional cardiology in treating complex congenital heart conditions, potentially reducing the need for open-heart surgery.
  • Advances in arrhythmia management offer improved quality of life and reduced risk of sudden cardiac death for CHD patients.
  • This review provides valuable insights for clinicians and researchers, guiding future research directions and clinical practice in pediatric and adult congenital cardiology.

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...